Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
-1.38M
-
Total reported value, excl. options
-
$354M
-
Value change
-
-$43.8M
-
Put/Call ratio
-
0.42
-
Number of buys
-
62
-
Number of sells
-
-52
-
Price
-
$14.47
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2014
165 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2014.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 106M outstanding shares and own 23.19% of the company stock.
Largest 10 shareholders include COLUMBIA WANGER ASSET MANAGEMENT LLC (3.27M shares), PERCEPTIVE ADVISORS LLC (2.81M shares), VANGUARD GROUP INC (2.29M shares), State Street Corp (1.86M shares), Point72 Asset Management, L.P. (1.55M shares), BlackRock Fund Advisors (1.52M shares), FMR LLC (1.26M shares), BlackRock Institutional Trust Company, N.A. (1.17M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (625K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (483K shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.